“Managment of Relapsed Refractory ALL With Inotuzumab During COVID-19. A Casr Report”. Mediterranean Journal of Hematology and Infectious Diseases 14, no. 1 (April 28, 2022): e2022043. Accessed May 24, 2026. https://www.mjhid.org/mjhid/article/view/4979.